ASHP Guidelines on Preventing Diversion of Controlled Substances.

Creator(s)

Philip W. Brummond
David F. Chen
William W. Churchill
John S. Clark
Kevin R. Dillon
Doina Dumitru
Lynn Eschenbacher
Toni Fera
Christopher R. Fortier
Kristine K. Gullickson
Kristen Jurakovich
Stan Kent
Jennifer Keonavong
Christine Marchese
Tricia Meyer
Lee B. Murdaugh
Richard K. Ogden Jr., Children's Mercy HospitalFollow
Brian O'Neal, Children's Mercy HospitalFollow
Steve Rough
Rafael Saenz
Jacob S. Smith

Document Type

Article

Publication Date

3-1-2017

Identifier

DOI: 10.2146/ajhp160919

Journal Title

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Volume

74

Issue

5

First Page

325

Last Page

348

MeSH Keywords

Controlled Substances; Delivery of Health Care; Drug and Narcotic Control; Guidelines as Topic; Health Personnel; Humans; Pharmacy; Substance-Related Disorders

Keywords

controlled substances; documentation; facility regulation and control; patient safety; prescription drug diversion; quality improvement

Recommended Citation

Brummond PW, Chen DF, Churchill WW, et al. ASHP Guidelines on Preventing Diversion of Controlled Substances. Am J Health Syst Pharm. 2017;74(5):325-348. doi:10.2146/ajhp160919